Skip to content
MarketScale
‹ Back to IndustriesHealthcare

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitor messaging suggests compliance testing and AI-ready compute are becoming early decisions, not afterthoughts. Medical Economics described 2026 as a period shaped by rapid technological change, regulatory scrutiny and ongoing economic uncertainty. Medical Design & Outsourcing’s MD&M West 2026 preview points to exhibitors highlighting test equipment, contract manufacturing and other launch support services.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By MarketScale Newsroom · Md&m WestMedical Device ManufacturingContract ManufacturingIso 13485
Share
Learn this in 60 seconds

Key facts, context, and what it means, in one minute.

:60
0:001:00
MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

Key takeaways

01

If a device roadmap includes AI features, the critical path shifts toward data and software evidence that regulators can audit, which means earlier lock-in of compute platforms and test plans, pulling verification and validation into supplier selection.

02

MD&M West exhibitor messaging suggests verification and validation capacity is becoming a procurement problem, with rentals and lab-ready gear positioned as a way to avoid booking delays and re-tests, according to Medical Design & Outsourcing.

03

With imaging and other new procedural and device concepts moving fast, manufacturing leaders should expect more frequent line-change decisions and component qualification work, as GE HealthCare's photon-counting CT CE mark reported by MedTech Dive and MDDI's New Technologies coverage illustrate.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

MD&M West 2026 runs Feb. 3-5 at the Anaheim Convention Center. In its preview, Medical Design & Outsourcing said it planned to visit contract manufacturers, design firms, suppliers and other medtech partners exhibiting at the show.

Medical Economics described 2026 as a moment shaped by rapid technological change, regulatory scrutiny and ongoing economic uncertainty. The publication did not tie those pressures to MD&M West, but they form the backdrop for how teams evaluate suppliers and development partners.

Anaheim exhibitors are pitching “audit-ready” as a product feature

In its MD&M West 2026 preview, Medical Design & Outsourcing said its editors planned to visit medical device contract manufacturers, design firms, suppliers and other medtech partners at the show.

Advanced Test Equipment Rentals (ATEC) said it rents test equipment spanning EMC/EMI, environmental, RF, electrical, and NDT applications, and it referenced standards such as IEC 60601, ISO, and MIL-STD, according to the MD&M West 2026 exhibitor preview published by Medical Design & Outsourcing.

Advantech, also featured in the MD&M West preview, positioned its medical-grade embedded computing around ISO 13485 certification and IEC 60601-1 compliance, and tied the platform story directly to secure connectivity, remote monitoring, and “AI-ready” data integration, according to Medical Design & Outsourcing. For device OEM operations teams, that messaging lands where it hurts: when compute choices are made late, verification plans get rewritten, and the whole build schedule slips.

AI is forcing earlier lock-in of compute, data, and postmarket plans

That combination changes how operations leaders should staff and sequence work. It pulls verification and validation left, into supplier selection and architecture. It also increases the cost of switching suppliers or components midstream, because the “new part” triggers an evidence cascade: re-testing, updated risk files, and revised software validation artifacts.

The MD&M West exhibitor emphasis on compliance-ready platforms and calibrated, certified equipment looks like a market response to that exact shift, even if the booth signage doesn’t say “FDA evidence package.”

Recent device news keeps reminding teams how fast product lines can change

MedTech Dive also reported that GE HealthCare secured a CE mark for its photon-counting CT device, putting competitive pressure into an imaging segment where buyers will scrutinize not only image quality but also service models, uptime, and integration roadmaps. New modalities tend to drive new accessories, new service parts, and new training requirements. Operations teams end up managing parallel supply chains during transitions.

MDDI’s New Technologies channel has been tracking the steady expansion of procedural and device concepts, from hypertension interventions to oncology platforms, illustrating the breadth of innovation that can quickly turn into manufacturing and supply chain work once programs move from early studies into scaled builds. The practical effect is that supplier qualification and line-change governance become constant, not episodic.

Where this lands in 2026 sourcing and launch planning

MD&M West 2026 is scheduled for Feb. 3-5 at the Anaheim Convention Center. Medical Design & Outsourcing’s preview said the event brings together medical device contract manufacturers, design firms, suppliers and other medtech partners.

The tactical move is to treat testing, calibration, and documentation capacity as capacity. It can be constrained. It can be bought. And it should be negotiated early, with service-level commitments that match launch dates, not “best effort” lab scheduling.

Questions to put in RFPs before the next design freeze

  • For embedded compute suppliers: What compliance and documentation support can you provide for the device standards a program requires, such as IEC 60601? (Medical Design & Outsourcing noted that exhibitor-submitted entries in its MD&M West 2026 preview were not fact-checked.)
  • For test and measurement partners: Which test categories do you support, such as EMC/EMI, environmental, RF, electrical, or NDT, and which standards do you reference for typical customer work? (Medical Design & Outsourcing reported exhibitor-submitted information that referenced standards such as IEC 60601, ISO, and MIL-STD.)
  • For contract manufacturers: Which component types and process capabilities do you support, and what cleanroom environment do you operate? (Medical Design & Outsourcing included exhibitor-submitted descriptions such as Class 8 (100,000) cleanrooms and capabilities like welding, grinding, and nitinol shape setting.)
  • For product teams: How are you accounting for the broader 2026 backdrop of rapid technological change, regulatory scrutiny and ongoing economic uncertainty described by Medical Economics?

Featured companies

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

MarketScale Newsroom
MarketScale NewsroomEditorial Team, MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz brings 23+ years of experience as chief medical physicist at Texas Oncology and personal insight as a breast cancer survivor, enabling her to guide patient support groups and advocate for accessible cancer care. She emphasizes AI's potential in auto-contouring and treatment planning while stressing the need for proper training, validation, and transparency before implementation.

  • 01Over 23 years at Texas Oncology integrating personal cancer survivor experience with clinical expertise to improve patient empathy and support group leadership
  • 02AI in oncology requires human oversight, validation, and transparency; auto-contouring and auto-planning must be combined with staff training and rigorous protocol testing before deployment
  • 03Texas Oncology prioritizes offering state-of-the-art cancer treatments closer to home, including for rural patients, to reduce travel and ensure consistent, personalized care

Sep 3, 2026

ADA endorsement puts Weave on the shortlist for dental front-office tech

ADA endorsement puts Weave on the shortlist for dental front-office tech

Weave was named the exclusive patient engagement platform endorsed for American Dental Association members in March 2026. It lands as practices add more front-office systems. Weave’s Practice Analytics, launched in 2023, adds real-time metrics tied to Dentrix, Open Dental, and Eaglesoft.

  • 01Endorsements are becoming a procurement accelerant in dental tech: the ADA Member Advantage designation can move Weave into “default vendor” conversations when practices refresh phone, texting, reminders, and payments.
  • 02Analytics is moving from retrospective reporting to daily work queues: Weave’s Practice Analytics is positioned around unscheduled treatment plans, cancellations, and time-between-treatments, metrics that can be assigned to staff, not just reviewed by owners (according to Dental Products Report).
  • 03This matters most for groups standardizing across multiple sites: Business Wire frames Weave Enterprise as built to centralize operations across dozens or hundreds of locations, turning “patient communication” into a rollout and governance problem, not a single-office tool choice.

Sep 3, 2026

Radiology deal flow is splitting in two: $8B radiopharma and 14-state mobile imaging rollups

Radiology deal flow is splitting in two: $8B radiopharma and 14-state mobile imaging rollups

Radiology consolidation in 2026 is widening into two operationally different tracks: very large upstream radiopharma and imaging-component deals, and regional service platforms that bring imaging capacity to hospitals via mobile units and leased equipment. Radiology Business reported Curium signed a definitive agreement to acquire Lantheus for up to $8B after earlier reports put a potential deal near $7B, while Align Capital Partners agreed to buy Boise-based Heritage Imaging, a mobile diagnostic provider serving facilities across 14 states. For health systems, the immediate impact shows up less in headlines than in procurement and staffing: vendor portfolios can change quickly after component M&A, while outsourced and mobile imaging platforms change how rural and community facilities source PET-CT, MRI, and nuclear medicine capacity. Radiology Today’s management guidance on radiology mergers points to integration discipline, physician alignment, and process as the determinants of whether consolidation translates into measurable access and throughput improvements on the ground.

  • 01The same word, “consolidation,” now covers two very different buying problems: upstream supply and R&D bets (radiopharma, components) versus front-line capacity (mobile imaging and outsourced service lines).
  • 02Heritage Imaging’s 14-state footprint is a concrete benchmark for how far a mobile imaging platform can spread before standardization of protocols, credentialing, and PACS/RIS interfaces becomes the real work.
  • 03When deal values move from “reported” to “definitive” (as with Curium and Lantheus), procurement teams should assume faster portfolio and contracting changes, and pull forward vendor roadmap reviews tied to nuclear medicine and theranostics growth plans.

Sep 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

MarketScale Newsroom
MarketScale Newsroom

Editorial Team

MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512